Tess Egginton
News
Astellas and YASKAWA to establish joint venture focused on cell therapy manufacturing
Astellas Pharma and YASKAWA Electric Corporation have signed a definitive agreement to establish a joint venture for the development of a cell therapy product...
Jazz Pharmaceuticals to acquire Chimerix
Jazz Pharmaceuticals and Chimerix have entered into a definitive agreement for Jazz to acquire Chimerix for $8.55 per share in cash, representing a total...
FDA approves Genentech’s TNKase in acute ischemic stroke
The U.S. Food and Drug Administration (FDA) has approved Genentech's TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke...
